We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$292M
AUM Growth
+$21.1M
Cap. Flow
-$146K
Cap. Flow %
-0.05%
Top 10 Hldgs %
19.9%
Holding
125
New
1
Increased
41
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$1.88M
2
CORT icon
Corcept Therapeutics
CORT
+$497K
3
BOX icon
Box
BOX
+$406K
4
EDIT icon
Editas Medicine
EDIT
+$328K
5
LOXO
Loxo Oncology, Inc
LOXO
+$308K

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$1.69M
2
NTRA icon
Natera
NTRA
+$1.15M
3
EPAM icon
EPAM Systems
EPAM
+$996K
4
RNG icon
RingCentral
RNG
+$820K
5
PAYC icon
Paycom
PAYC
+$799K

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 22.23%
3 Communication Services 12.4%
4 Consumer Discretionary 10.65%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICE icon
26
Intercontinental Exchange
ICE
$85.6B
$2.79M 0.96%
37,249
– –
CVNA icon
27
Carvana
CVNA
$68.6B
$2.78M 0.95%
231,435
– –
WWE
28
DELISTED
World Wrestling Entertainment
WWE
$2.74M 0.94%
28,505
-3,427
-11% -$283K
WDAY icon
29
Workday
WDAY
$39.6B
$2.73M 0.94%
18,681
– –
LVS icon
30
Las Vegas Sands
LVS
$31.7B
$2.58M 0.88%
43,116
– –
PAYC icon
31
Paycom
PAYC
$7.64B
$2.55M 0.87%
16,432
-5,938
-27% -$799K
CLR
32
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.53M 0.87%
37,834
– –
GDOT icon
33
Green Dot
GDOT
$743M
$2.5M 0.86%
28,530
– –
TXRH icon
34
Texas Roadhouse
TXRH
$13.5B
$2.5M 0.86%
36,129
+1,605
+5% +$109K
TWLO icon
35
Twilio
TWLO
$30B
$2.5M 0.86%
29,153
-9,320
-24% -$681K
MMSI icon
36
Merit Medical Systems
MMSI
$5.08B
$2.49M 0.86%
41,276
– –
LOXO
37
DELISTED
Loxo Oncology, Inc
LOXO
$2.48M 0.85%
14,247
+1,835
+15% +$308K
FTNT icon
38
Fortinet
FTNT
$119B
$2.4M 0.82%
130,780
– –
GHDX
39
DELISTED
Genomic Health, Inc.
GHDX
$2.39M 0.82%
34,459
-1,834
-5% -$107K
OMER icon
40
Omeros
OMER
$857M
$2.36M 0.81%
95,755
– –
MEDP icon
41
Medpace
MEDP
$16.1B
$2.36M 0.81%
39,771
– –
MTDR icon
42
Matador Resources
MTDR
$6.2B
$2.31M 0.79%
70,077
-5,482
-7% -$175K
RARE icon
43
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.29M 0.79%
28,746
+1,672
+6% +$136K
CCOI icon
44
Cogent Communications
CCOI
$676M
$2.29M 0.79%
40,880
+2,413
+6% +$129K
APPF icon
45
AppFolio
APPF
$6.38B
$2.29M 0.79%
28,821
– –
SFIX
46
Stitch Fix
SFIX
$536M
$2.26M 0.77%
53,523
-6,435
-11% -$235K
IPAR icon
47
Interparfums
IPAR
$3.99B
$2.24M 0.77%
34,864
+1,785
+5% +$110K
MASI
48
DELISTED
Masimo
MASI
$2.22M 0.76%
17,996
-5,306
-23% -$589K
NEWR
49
DELISTED
New Relic, Inc.
NEWR
$2.2M 0.76%
22,968
+2,662
+13% +$276K
IPGP icon
50
IPG Photonics
IPGP
$3.61B
$2.19M 0.75%
13,816
– –
1
2
3 4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Capital Impact Advisors held 125 positions worth $292M, up 7.8% from $270M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 1.6%. Capital Impact Advisors opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2018 buy was Karyopharm Therapeutics: 6,800 shares worth $1.74M.
  • Capital Impact Advisors added most to Corcept Therapeutics in Q3 2018, an estimated $497K increase.
  • Capital Impact Advisors's biggest Q3 2018 reduction was Natera, cutting an estimated $1.15M.
  • Capital Impact Advisors fully exited Super Micro Computer in Q3 2018, selling an estimated $1.69M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $292M portfolio in Q3 2018.
  • Capital Impact Advisors opened 1 new position and closed 1 in Q3 2018.
  • Capital Impact Advisors's portfolio value rose 7.8% quarter-over-quarter to $292M.

Based on Capital Impact Advisors's 13F filing for Q3 2018, filed 19 Oct 2018.